Recombinetics, Inc. is engaged in development of proprietary gene repair and gene-editing technology. The company uses its technologies in the agricultural arena to accelerate the breeding of natural characteristics into pigs and other livestock to enhance their health and welfare, and advance worldwide food production and safety. In the biomedical arena, Recombinetics also applies its genome-editing solutions and TALEN technologies to create viable large animal models for human disease research as part of the development of therapeutic compounds, medical devices, and protocols. With some key in the firm's gene editing technology, Recombinetics is moving on to the commercialization phase with hopes of making big dents in three markets: livestock health, human medical research and regenerative medicine.
